Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Severe Intraoperative Hyperglycemia on Infection Rate After Elective Intracranial Interventions

NCT05236751 is registered in ClinicalTrials.gov with Boston Medical Center as lead sponsor.

NCT NCT05236751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05236751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Severe Intraoperative Hyperglycemia on Infection Rate After Elective Intracranial Interventions
Lead sponsor
Boston Medical Center
Phase
Observational
Overall status
Completed
Start date
May 24, 2021
Completion date
May 13, 2023
Enrollment
52 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hyperglycemia, postoperative infection